Emcure Pharmaceuticals fundamental analysis

EMCURE

1408

6.20 (0.44%)
Last updated on 3 Jan, 2026 | 13:09 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Emcure Pharmaceuticals Fundamentals

P/E Ratio

34.18

P/B Ratio

5.72

Div. Yield

0.21

Sector P/E

72.47

Sector P/B

1.02

Sec. Div. Yield

0.56

Emcure Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 34.18, compared to the sector average of 72.47. Its P/B Ratio stands at 5.72, while the sector’s is 1.02. In terms of returns, the stock offers a Dividend Yield of 0.21%, which is than the sector’s 0.56%.

Emcure Pharmaceuticals Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Average

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Good

On its scorecard, Emcure Pharmaceuticals reflects: Price – Expensive, Growth – Average, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.